Pub Date : 2026-02-06DOI: 10.1097/ALN.0000000000005904
Elizabeth M Putnam, Randolph H Steadman, Douglas A Colquhoun
Simulation-based training is a proven modality for developing critical technical and nontechnical skills in anesthesiology. While simulation-based training has been linked to improved patient outcomes, team performance, and reduced malpractice risk, postresidency simulation remains underutilized. Drawing on parallels from other high-stakes professions and a faculty-focused simulation program developed by the authors, they propose a model for embedding simulation-based training into clinical practice using real-world quality data, subspecialty alignment, and interprofessional collaboration. When implemented, simulation-based training should become part of continuing professional development for attending anesthesiologists, supported by departmental leadership and enhanced by interprofessional collaboration.
{"title":"Simulation beyond Residency: A Call to Action for Anesthesiology Leaders and Perioperative Teams.","authors":"Elizabeth M Putnam, Randolph H Steadman, Douglas A Colquhoun","doi":"10.1097/ALN.0000000000005904","DOIUrl":"https://doi.org/10.1097/ALN.0000000000005904","url":null,"abstract":"<p><p>Simulation-based training is a proven modality for developing critical technical and nontechnical skills in anesthesiology. While simulation-based training has been linked to improved patient outcomes, team performance, and reduced malpractice risk, postresidency simulation remains underutilized. Drawing on parallels from other high-stakes professions and a faculty-focused simulation program developed by the authors, they propose a model for embedding simulation-based training into clinical practice using real-world quality data, subspecialty alignment, and interprofessional collaboration. When implemented, simulation-based training should become part of continuing professional development for attending anesthesiologists, supported by departmental leadership and enhanced by interprofessional collaboration.</p>","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146130942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-05DOI: 10.1097/ALN.0000000000005931
Maarten A van Lemmen, Jeffry Florian, Zhihua Li, Monique van Velzen, Erik Olofsen, Albert Dahan, Marieke Niesters, Elise Sarton, Rutger van der Schrier
Background: Since current opioid overdose deaths occur mainly from potent synthetic opioids with high affinity for the opioid receptor, such as fentanyl and carfentanil, it is important to determine the efficacy of naloxone, particularly the intranasal formulation, in reversing opioid-induced respiratory depression. This study evaluated effectiveness of 4 mg intranasal naloxone (Narcan®) in reversing moderate respiratory depression induced by fentanyl and sufentanil, in opioid-naïve individuals and self-reported daily opioid users. Sufentanil was compared to fentanyl because of its higher affinity for the opioid receptor than fentanyl.
Methods: In this prospective, crossover trial, 12 opioid-naïve individuals and 18 daily opioid users (morphine milligram equivalent of 291 (range 60-2250 mg/day) received continuous fentanyl or sufentanil infusions, titrated to achieve 30-40% reduction in ventilation (V̇E). Participants were administered Narcan® during steady-state respiratory depression. Primary endpoints included time to reversal of diminished V̇E and elevated end-tidal carbon dioxide concentration (pCO2).
Results: Narcan® restored V̇E within 2-4 min across all participants but showed delayed reversal of end-tidal pCO2 (11-17 min), with pCO2 recovery during sufentanil exposure in just 8 opioid-naïve individuals and 10 daily opioid users. Hysteresis analysis showed for V̇E-reversal onset/offset time (blood-effect-site equilibration half-life) of 0-1 min and end-tidal pCO2 2-11 min. Because of withdrawal symptoms, seven of eighteen daily opioid users participated once in the study. Study limitations included continuous opioid infusions that do not occur in real-world overdose settings.
Conclusion: A single Narcan® dose reversed moderate fentanyl- and sufentanil-induced respiratory depression, though effectiveness varied by endpoint and opioid receptor affinity. Rapid V̇E-recovery suggests clinical utility of intranasal naloxone, but delayed and sometimes incomplete recovery of end-tidal pCO2, particularly during exposure to the high-affinity opioid sufentanil, indicating reversal inefficacy and persistence of respiratory instability. Further studies are needed to address optimal naloxone doses and alternative formulations to address high-dose potent opioid threats.
{"title":"Intranasal naloxone reversal of opioid-induced respiratory depression in opioid-naïve individuals and self-reported daily opioid users.","authors":"Maarten A van Lemmen, Jeffry Florian, Zhihua Li, Monique van Velzen, Erik Olofsen, Albert Dahan, Marieke Niesters, Elise Sarton, Rutger van der Schrier","doi":"10.1097/ALN.0000000000005931","DOIUrl":"https://doi.org/10.1097/ALN.0000000000005931","url":null,"abstract":"<p><strong>Background: </strong>Since current opioid overdose deaths occur mainly from potent synthetic opioids with high affinity for the opioid receptor, such as fentanyl and carfentanil, it is important to determine the efficacy of naloxone, particularly the intranasal formulation, in reversing opioid-induced respiratory depression. This study evaluated effectiveness of 4 mg intranasal naloxone (Narcan®) in reversing moderate respiratory depression induced by fentanyl and sufentanil, in opioid-naïve individuals and self-reported daily opioid users. Sufentanil was compared to fentanyl because of its higher affinity for the opioid receptor than fentanyl.</p><p><strong>Methods: </strong>In this prospective, crossover trial, 12 opioid-naïve individuals and 18 daily opioid users (morphine milligram equivalent of 291 (range 60-2250 mg/day) received continuous fentanyl or sufentanil infusions, titrated to achieve 30-40% reduction in ventilation (V̇E). Participants were administered Narcan® during steady-state respiratory depression. Primary endpoints included time to reversal of diminished V̇E and elevated end-tidal carbon dioxide concentration (pCO2).</p><p><strong>Results: </strong>Narcan® restored V̇E within 2-4 min across all participants but showed delayed reversal of end-tidal pCO2 (11-17 min), with pCO2 recovery during sufentanil exposure in just 8 opioid-naïve individuals and 10 daily opioid users. Hysteresis analysis showed for V̇E-reversal onset/offset time (blood-effect-site equilibration half-life) of 0-1 min and end-tidal pCO2 2-11 min. Because of withdrawal symptoms, seven of eighteen daily opioid users participated once in the study. Study limitations included continuous opioid infusions that do not occur in real-world overdose settings.</p><p><strong>Conclusion: </strong>A single Narcan® dose reversed moderate fentanyl- and sufentanil-induced respiratory depression, though effectiveness varied by endpoint and opioid receptor affinity. Rapid V̇E-recovery suggests clinical utility of intranasal naloxone, but delayed and sometimes incomplete recovery of end-tidal pCO2, particularly during exposure to the high-affinity opioid sufentanil, indicating reversal inefficacy and persistence of respiratory instability. Further studies are needed to address optimal naloxone doses and alternative formulations to address high-dose potent opioid threats.</p>","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146123511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-05DOI: 10.1097/ALN.0000000000005974
Fei Chen, Samuel T Belgique, Sam Hawke, Cullen Jackson, John D Mitchell, Kristina Sullivan, Christy K Boscardin, Chelsea Willie, Bahjat F Qaqish, Susan M Martinelli
Background: Professionalism is a core competency in graduate medical education, yet research examining specialty-specific professionalism perceptions between trainees and faculty remains limited, particularly regarding the influence of role and institutional culture on these perceptions. This study examined how anesthesiology trainees and attendings perceive unprofessional behavior and whether these perceptions differ based on participant characteristics.
Methods: A multi-site cross-sectional survey was conducted at five anesthesiology residency programs from February to March 2024. Participants rated degree of unprofessionalism on19 workplace vignettes depicting potentially unprofessional behaviors using a 7-point Likert scale. Vignettes were categorized into five themes: Verbal, Supervision, Quality, Time, and Engagement. Proportional odds models examined differences in ratings based on role (trainee vs. attending), adjusting for gender, race, underrepresented status, and institution.
Results: Among 369 respondents (153 trainees, 216 attendings; 35.9% response rate), perceptions varied by scenario and participant characteristics. Six vignettes were more consistently rated as unprofessional (>80% unprofessional ratings), while four showed higher variability (<50% unprofessional ratings). Significant institutional differences were observed in five vignettes (Odds ratios [ORs] <0.14 or >3.7, p < 0.0001 to 0.027). Age influenced ratings of five vignettes (ORs = 0.75, 1.68, 1.63, 1.35 and 1.31 respectively, p <0.0001 to 0.027), while gender, race and underrepresented status showed no significant differences. After adjusting for demographics, trainees and attendings differed significantly in their ratings of 10 vignettes (p <0.0001 to 0.033). Attendings rated nine scenarios as more unprofessional than trainees (ORs ranging from 0.26 to 0.50), while trainees rated only one scenario as more unprofessional than attendings (OR = 2.01).
Conclusions: Perceptions of unprofessional behavior among anesthesiology professionals vary significantly by role and institution. These findings underscore the importance of context-sensitive approaches to professionalism education that acknowledge diverse perspectives and institutional cultures while maintaining core professional standards.
{"title":"Professionalism Perceptions: A Comparison of Anesthesiology Trainees and Attendings.","authors":"Fei Chen, Samuel T Belgique, Sam Hawke, Cullen Jackson, John D Mitchell, Kristina Sullivan, Christy K Boscardin, Chelsea Willie, Bahjat F Qaqish, Susan M Martinelli","doi":"10.1097/ALN.0000000000005974","DOIUrl":"https://doi.org/10.1097/ALN.0000000000005974","url":null,"abstract":"<p><strong>Background: </strong>Professionalism is a core competency in graduate medical education, yet research examining specialty-specific professionalism perceptions between trainees and faculty remains limited, particularly regarding the influence of role and institutional culture on these perceptions. This study examined how anesthesiology trainees and attendings perceive unprofessional behavior and whether these perceptions differ based on participant characteristics.</p><p><strong>Methods: </strong>A multi-site cross-sectional survey was conducted at five anesthesiology residency programs from February to March 2024. Participants rated degree of unprofessionalism on19 workplace vignettes depicting potentially unprofessional behaviors using a 7-point Likert scale. Vignettes were categorized into five themes: Verbal, Supervision, Quality, Time, and Engagement. Proportional odds models examined differences in ratings based on role (trainee vs. attending), adjusting for gender, race, underrepresented status, and institution.</p><p><strong>Results: </strong>Among 369 respondents (153 trainees, 216 attendings; 35.9% response rate), perceptions varied by scenario and participant characteristics. Six vignettes were more consistently rated as unprofessional (>80% unprofessional ratings), while four showed higher variability (<50% unprofessional ratings). Significant institutional differences were observed in five vignettes (Odds ratios [ORs] <0.14 or >3.7, p < 0.0001 to 0.027). Age influenced ratings of five vignettes (ORs = 0.75, 1.68, 1.63, 1.35 and 1.31 respectively, p <0.0001 to 0.027), while gender, race and underrepresented status showed no significant differences. After adjusting for demographics, trainees and attendings differed significantly in their ratings of 10 vignettes (p <0.0001 to 0.033). Attendings rated nine scenarios as more unprofessional than trainees (ORs ranging from 0.26 to 0.50), while trainees rated only one scenario as more unprofessional than attendings (OR = 2.01).</p><p><strong>Conclusions: </strong>Perceptions of unprofessional behavior among anesthesiology professionals vary significantly by role and institution. These findings underscore the importance of context-sensitive approaches to professionalism education that acknowledge diverse perspectives and institutional cultures while maintaining core professional standards.</p>","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146130971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-03DOI: 10.1097/ALN.0000000000005914
Markus Huber
{"title":"Illustrating Bayesian Indices of Effect Existence and Practical Significance in Anesthesiology Trials.","authors":"Markus Huber","doi":"10.1097/ALN.0000000000005914","DOIUrl":"https://doi.org/10.1097/ALN.0000000000005914","url":null,"abstract":"","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146123546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-03DOI: 10.1097/ALN.0000000000005968
Pilleriin Sikka, May Ching Ngo, Sherry Hu, Tiara Boyd Wilkerson, Miranda Shull, Kathryn Imbordino, Toru Ishii, Makoto Kawai, Ben Deverett, Harrison Shong-Wen Chow, Boris D Heifets
Background: Dreaming during anesthesia is common and may have mental health benefits. However, systematic research on its incidence and outcomes in clinical settings remains limited. We implemented a standardized propofol-based, EEG-guided emergence bundle to facilitate a pre-emergence state conducive to dreaming, integrating it into routine care to assess adherence, dream recall, patient experience, and safety.
Methods: In this prospective quality improvement feasibility study, 474 patients undergoing elective surgeries were anesthetized according to a five-element protocol: (1) pre-induction verbal priming about dreaming; (2) propofol as emergence anesthetic; (3) EEG (SedLine) monitoring to guide emergence; (4) ≥10 minutes of minimized stimulation before emergence; and (5) immediate post-emergence interviews regarding dream recall, valence, and subjective sleep quality. In a subset of breast cancer patients (N = 106), preregistered analyses examined post-anesthesia recovery unit (PACU) outcomes.
Results: Of 452 patients interviewed, 69% reported dreaming. Among 57 patients with full adherence to all protocol elements, 93% reported dreaming. Most dreams were positive (86%), with no very negative dreams. Dreamers (M = 9.16 ± 1.57) reported higher sleep quality than non-dreamers (M = 7.65 ± 2.86; p < 0.001). The protocol was safe, with no intraoperative awareness. Recovery times, analgesic and antiemetic use did not differ between groups. Feasibility was supported by high adherence to most elements (100% for verbal priming and propofol use; ≥90% for EEG monitoring, 95% for immediate interviews), though adherence to the no-stimulation emergence period was low (14%).
Conclusions: We demonstrate the feasibility of using a standardized anesthetic protocol in real-world clinical setting to facilitate anesthesia dreaming. With full adherence, dream recall rates approached experimental studies. The protocol was safe and linked to positive patient experiences, although dream recall was unrelated to PACU outcomes. These findings align with ERAS principles and provide a foundation for exploring potential therapeutic applications of anesthesia dreaming.
{"title":"Feasibility of a Multicomponent Protocol to Promote Dreaming during Surgical Anesthesia.","authors":"Pilleriin Sikka, May Ching Ngo, Sherry Hu, Tiara Boyd Wilkerson, Miranda Shull, Kathryn Imbordino, Toru Ishii, Makoto Kawai, Ben Deverett, Harrison Shong-Wen Chow, Boris D Heifets","doi":"10.1097/ALN.0000000000005968","DOIUrl":"https://doi.org/10.1097/ALN.0000000000005968","url":null,"abstract":"<p><strong>Background: </strong>Dreaming during anesthesia is common and may have mental health benefits. However, systematic research on its incidence and outcomes in clinical settings remains limited. We implemented a standardized propofol-based, EEG-guided emergence bundle to facilitate a pre-emergence state conducive to dreaming, integrating it into routine care to assess adherence, dream recall, patient experience, and safety.</p><p><strong>Methods: </strong>In this prospective quality improvement feasibility study, 474 patients undergoing elective surgeries were anesthetized according to a five-element protocol: (1) pre-induction verbal priming about dreaming; (2) propofol as emergence anesthetic; (3) EEG (SedLine) monitoring to guide emergence; (4) ≥10 minutes of minimized stimulation before emergence; and (5) immediate post-emergence interviews regarding dream recall, valence, and subjective sleep quality. In a subset of breast cancer patients (N = 106), preregistered analyses examined post-anesthesia recovery unit (PACU) outcomes.</p><p><strong>Results: </strong>Of 452 patients interviewed, 69% reported dreaming. Among 57 patients with full adherence to all protocol elements, 93% reported dreaming. Most dreams were positive (86%), with no very negative dreams. Dreamers (M = 9.16 ± 1.57) reported higher sleep quality than non-dreamers (M = 7.65 ± 2.86; p < 0.001). The protocol was safe, with no intraoperative awareness. Recovery times, analgesic and antiemetic use did not differ between groups. Feasibility was supported by high adherence to most elements (100% for verbal priming and propofol use; ≥90% for EEG monitoring, 95% for immediate interviews), though adherence to the no-stimulation emergence period was low (14%).</p><p><strong>Conclusions: </strong>We demonstrate the feasibility of using a standardized anesthetic protocol in real-world clinical setting to facilitate anesthesia dreaming. With full adherence, dream recall rates approached experimental studies. The protocol was safe and linked to positive patient experiences, although dream recall was unrelated to PACU outcomes. These findings align with ERAS principles and provide a foundation for exploring potential therapeutic applications of anesthesia dreaming.</p>","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146111891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-03DOI: 10.1097/ALN.0000000000005909
Bo Tang, Lijian Pei, Jie Zhou, Mingli Li
{"title":"Early Diagnosis of Postpartum Obturator Neuropathy with Magnetic Resonance Imaging.","authors":"Bo Tang, Lijian Pei, Jie Zhou, Mingli Li","doi":"10.1097/ALN.0000000000005909","DOIUrl":"https://doi.org/10.1097/ALN.0000000000005909","url":null,"abstract":"","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146123565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-20DOI: 10.1097/ALN.0000000000005805
Andrew Bowdle, Srdjan Jelacic, Kelly E Michaelsen
{"title":"Let's Say Goodbye to Acceleromyographic Twitch Monitoring: Reply.","authors":"Andrew Bowdle, Srdjan Jelacic, Kelly E Michaelsen","doi":"10.1097/ALN.0000000000005805","DOIUrl":"10.1097/ALN.0000000000005805","url":null,"abstract":"","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":"144 2","pages":"493-494"},"PeriodicalIF":9.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-05DOI: 10.1097/ALN.0000000000005830
Shira Zelber-Sagi, Vikas N O'Reilly-Shah, Ashish K Khanna, Peter Rock, Itay Bentov
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) and related advanced fibrosis are associated with poor hepatic and extrahepatic outcomes. However, the role of liver fibrosis in surgery-related mortality remains unclear. The authors aimed to assess the association between a widely used liver fibrosis marker, the Fibrosis-4 (FIB-4) score, and 30-day postoperative mortality and complications.
Methods: A multicenter historical cohort of patients underwent general anesthesia. Data were obtained from the Multicenter Perioperative Outcomes Group dataset. Exclusion criteria included known liver diseases other than MASLD, hepatic failure, and alcohol use disorder. Risk of liver fibrosis was calculated using the FIB-4 score and categorized using the MASLD accepted predefined ranges. Mixed-effects multivariable logistic regression models were built to assess the adjusted conditional odds ratio (cOR) for the primary outcome of mortality and secondary outcomes of acute kidney injury, myocardial injury, and postoperative pulmonary complications.
Results: The final cohort size for the primary outcome of mortality was 1,325,102. Compared to the low-risk FIB-4 category (1.3 or less), the inconclusive FIB-4 category (1.3 to 2.67) was associated with an adjusted cOR of 1.533-fold for mortality (99.75% CI, 1.453 to 1.616), while the elevated category (FIB-4, 2.67 or greater) was associated with an adjusted cOR of 3.765-fold (99.75% CI, 3.572 to 3.969). This association persisted with the application of age-adjusted FIB-4 cutoffs in stratification by age category. A dose-response association was also observed between FIB-4 as a continuous variable and mortality. Among secondary outcomes, elevated FIB-4 was associated with a postoperative cOR of 1.515 for acute kidney injury (99.75% CI, 1.435 to 1.598), a cOR of 1.657 for myocardial injury (99.75% CI, 1.401 to 1.960), and a cOR of 1.323 for postoperative pulmonary complications (99.75% CI, 1.280 to 1.369).
Conclusions: The FIB-4 score is associated with postoperative mortality and complications in a population without clinically apparent liver disease, and evaluation may have value in preoperative patient counseling and optimization.
背景:代谢功能障碍相关的脂肪变性肝病(MASLD)和相关的晚期纤维化与肝脏和肝外预后不良相关。然而,肝纤维化在手术相关死亡率中的作用仍不清楚。我们旨在评估广泛使用的肝纤维化标志物纤维化-4 (FIB-4)评分与术后30天死亡率和并发症之间的关系。方法:对接受全身麻醉的患者进行多中心历史队列研究。数据来自多中心围手术期预后组(MPOG)数据集。排除标准包括已知的除MASLD以外的肝脏疾病、肝功能衰竭和酒精使用障碍。使用FIB-4评分计算肝纤维化风险,并使用MASLD接受的预定义范围进行分类。建立混合效应多变量logistic回归模型,评估死亡率主要结局和急性肾损伤、心肌损伤和术后肺部并发症次要结局的调整条件优势比(cOR)。结果:死亡率主要结局的最终队列大小为1,325,102。与低危FIB-4组(≤1.3)相比,不确定FIB-4组(1.3-2.67)与校正后的死亡率比值为1.533倍[99.75% CI 1.453-1.616],而高危FIB-4组(≥2.67)与校正后的死亡率比值为3.765倍[99.75% CI 3.572-3.969]。在按年龄分类分层时,使用年龄调整的FIB-4截断值仍然存在这种关联。FIB-4作为一个连续变量与死亡率之间也观察到剂量-反应相关性。在次要结局中,急性肾损伤时FIB-4升高与术后cOR相关,为1.515 [99.75% CI 1.435-1.598],心肌损伤时cOR为1.657 [99.75% CI 1.401-1.960],术后肺部并发症时cOR为1.323 [99.75% CI 1.290 -1.369]。结论:FIB-4评分与无临床明显肝病人群的术后死亡率和并发症相关,评估可能对术前患者咨询和优化有价值。
{"title":"Association of Liver Fibrosis Fibrosis-4 Score with Perioperative Complications and Mortality: A Retrospective Multicenter Analysis.","authors":"Shira Zelber-Sagi, Vikas N O'Reilly-Shah, Ashish K Khanna, Peter Rock, Itay Bentov","doi":"10.1097/ALN.0000000000005830","DOIUrl":"10.1097/ALN.0000000000005830","url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatotic liver disease (MASLD) and related advanced fibrosis are associated with poor hepatic and extrahepatic outcomes. However, the role of liver fibrosis in surgery-related mortality remains unclear. The authors aimed to assess the association between a widely used liver fibrosis marker, the Fibrosis-4 (FIB-4) score, and 30-day postoperative mortality and complications.</p><p><strong>Methods: </strong>A multicenter historical cohort of patients underwent general anesthesia. Data were obtained from the Multicenter Perioperative Outcomes Group dataset. Exclusion criteria included known liver diseases other than MASLD, hepatic failure, and alcohol use disorder. Risk of liver fibrosis was calculated using the FIB-4 score and categorized using the MASLD accepted predefined ranges. Mixed-effects multivariable logistic regression models were built to assess the adjusted conditional odds ratio (cOR) for the primary outcome of mortality and secondary outcomes of acute kidney injury, myocardial injury, and postoperative pulmonary complications.</p><p><strong>Results: </strong>The final cohort size for the primary outcome of mortality was 1,325,102. Compared to the low-risk FIB-4 category (1.3 or less), the inconclusive FIB-4 category (1.3 to 2.67) was associated with an adjusted cOR of 1.533-fold for mortality (99.75% CI, 1.453 to 1.616), while the elevated category (FIB-4, 2.67 or greater) was associated with an adjusted cOR of 3.765-fold (99.75% CI, 3.572 to 3.969). This association persisted with the application of age-adjusted FIB-4 cutoffs in stratification by age category. A dose-response association was also observed between FIB-4 as a continuous variable and mortality. Among secondary outcomes, elevated FIB-4 was associated with a postoperative cOR of 1.515 for acute kidney injury (99.75% CI, 1.435 to 1.598), a cOR of 1.657 for myocardial injury (99.75% CI, 1.401 to 1.960), and a cOR of 1.323 for postoperative pulmonary complications (99.75% CI, 1.280 to 1.369).</p><p><strong>Conclusions: </strong>The FIB-4 score is associated with postoperative mortality and complications in a population without clinically apparent liver disease, and evaluation may have value in preoperative patient counseling and optimization.</p>","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":" ","pages":"365-378"},"PeriodicalIF":9.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-25DOI: 10.1097/ALN.0000000000005811
Heungjo Kim, Byung Hak Jin, Seungwon Yang, Jongsung Hahn, Soyoung Kang, Dasohm Kim, Hongjae Lee, Hoyoung Kwack, Soon Uk Chae, Soo Kyung Bae, Jin Wi, Min Jung Chang
{"title":"Effect of Extracorporeal Membrane Oxygenation Flow Rate on Midazolam Clearance: A Population Pharmacokinetic Study.","authors":"Heungjo Kim, Byung Hak Jin, Seungwon Yang, Jongsung Hahn, Soyoung Kang, Dasohm Kim, Hongjae Lee, Hoyoung Kwack, Soon Uk Chae, Soo Kyung Bae, Jin Wi, Min Jung Chang","doi":"10.1097/ALN.0000000000005811","DOIUrl":"10.1097/ALN.0000000000005811","url":null,"abstract":"","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":" ","pages":"485-488"},"PeriodicalIF":9.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12777615/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}